India to Launch First Indigenous H5N1 Chicken Vaccine to Strengthen Poultry Disease Control
ICAR-NIHSAD-developed vaccine targets H5N1 Clade 2.3.2.1a, aiming to reduce bird flu risks, poultry-sector losses and disruptions to trade Bhopal | 18 November 2026 India is set to introduce its first indigenous inactivated H5N1 vaccine for chickens, targeting
ICAR-NIHSAD-developed vaccine targets H5N1 Clade 2.3.2.1a, aiming to reduce bird flu risks, poultry-sector losses and disruptions to trade
Bhopal | 18 November 2026
India is set to introduce its first indigenous inactivated H5N1 vaccine for chickens, targeting the Highly Pathogenic Avian Influenza (HPAI) virus of Clade 2.3.2.1a. Union Agriculture and Farmers Welfare Minister Shivraj Singh Chouhan will dedicate the vaccine to the nation on 20 November 2026 at the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD), Bhopal.
Developed indigenously by ICAR-NIHSAD, the vaccine is designed to provide protection against H5N1 Clade 2.3.2.1a strains circulating in India. The development marks an important step in strengthening the country’s preparedness against bird flu, a disease that can cause severe losses to poultry farms and disrupt the wider poultry supply chain.
Bird flu outbreaks pose significant risks to India’s poultry industry
Highly Pathogenic Avian Influenza, commonly known as bird flu, is a serious poultry disease that can cause mortality of nearly 100% among infected birds. Outbreaks can lead to large-scale culling, trade restrictions and substantial financial losses for poultry farmers.
Since the first detection of the disease in India in 2006, the country has reported more than 500 combined outbreaks involving H5N1 and H5N8 subtypes.
The PIB release highlights the potential economic consequences of a major outbreak. It states that India’s GDP growth could decline by up to 1.5% in a severe bird flu scenario, while more than 20% of the country’s poultry population could be at risk if the disease spreads without effective control.
The 2006 outbreak resulted in estimated direct and indirect losses of ₹2,200–3,000 crore. An outbreak in Manipur also caused losses equivalent to 0.5% of the state’s GDP.
Vaccine targets the H5N1 strain responsible for major poultry outbreaks
Studies cited in the release identify H5N1 Clade 2.3.2.1a as the strain responsible for most bird flu outbreaks in chickens. In recent times, infections involving this strain have also been detected in different animal species, including mammals, alongside three reported human cases.
The release notes that no specific commercial vaccine is currently available against H5N1 Clade 2.3.2.1a. The indigenous vaccine developed by ICAR-NIHSAD is intended to address this gap by targeting the virus strains circulating in India.
Controlling the spread of the virus is important not only for protecting poultry farms but also for reducing the risk of transmission to other animal species and humans.
Implications for poultry, food service and hospitality
The launch has relevance beyond poultry farming, given the role of chicken and other poultry products in India’s food supply chain.
1. Greater focus on poultry-sector biosecurity
An indigenous vaccine targeting a major circulating H5N1 strain could strengthen India’s disease-control preparedness. Effective disease management is important for poultry farmers, hatcheries, breeders and other businesses across the poultry value chain.
2. Supply-chain stability for hotels and restaurants
Chicken is a widely used ingredient across hotels, restaurants, catering businesses and institutional kitchens. Bird flu outbreaks can affect poultry availability, prices and trade. Improved disease-control capabilities could help reduce the risk of major supply disruptions, subject to effective implementation.
3. Reduced exposure to outbreak-related financial losses
Large-scale culling and trade restrictions can affect poultry producers and businesses dependent on poultry supplies. Strengthening preventive measures could support greater resilience across the sector.
4. Importance of consumer confidence and food-sector preparedness
Disease outbreaks can create concerns across food supply chains. Stronger surveillance and control measures, alongside appropriate food-safety communication, remain important for maintaining confidence in poultry products.
Key Highlights
- First indigenous vaccine: India’s first inactivated H5N1 chicken vaccine targeting Clade 2.3.2.1a.
- Developed by: ICAR-National Institute of High Security Animal Diseases, Bhopal.
- Dedication: Union Agriculture Minister Shivraj Singh Chouhan to dedicate the vaccine on 20 November 2026.
- Outbreak history: More than 500 combined H5N1 and H5N8 outbreaks reported in India since 2006.
- Economic impact: The 2006 bird flu outbreak caused estimated direct and indirect losses of ₹2,200–3,000 crore.
- Industry risk: The release estimates that more than 20% of India’s poultry population could be at risk in an uncontrolled outbreak scenario.
- Vaccine objective: To provide protection against H5N1 Clade 2.3.2.1a strains circulating in India.
Industry Takeaway
India’s first indigenous H5N1 Clade 2.3.2.1a chicken vaccine represents a significant development in poultry disease-control preparedness. For poultry producers, the wider food industry and hospitality businesses, the key concern is the potential to reduce the impact of bird flu outbreaks on production, availability and market stability.
The vaccine’s eventual contribution will depend on its deployment, coverage and integration with broader disease surveillance and biosecurity measures. For hotels, restaurants and caterers, a stronger poultry-health framework could support more resilient sourcing of chicken, an important ingredient across India’s food service industry.